Pasar al contenido principal

ESTUDIO SOBRE EL PAPEL DE LA FAMILIA DE IKAROS EN LA REGULACION DE LAS ALTERACIONES NEUROINMUNOLOGICAS EN LA ESQUIZOFRENIA

PID2021-122258OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Thalamic Foxp2 regulates output connectivity and sensory-motor impairments in a model of Huntington's Disease

  • Rodríguez-Urgellés, Ened
  • Casas-Torremocha, Diana
  • Sancho-Balsells, Anna
  • Ballasch, Iván
  • García-García, Esther
  • Miquel-Rio, Lluís
  • Manasanch, Arnau
  • Del Castillo, Ignacio
  • Chen, Wanqi
  • Pupak, Anika
  • Brito, Veronica
  • Tornero, Daniel
  • Rodríguez, Manuel J.
  • Bortolozzi, Analía
  • Sanchez-Vives, Maria V.
  • Giralt, Albert
  • Alberch, Jordi
Huntington's Disease (HD) is a disorder that affects body movements. Altered glutamatergic innervation of the striatum is a major hallmark of the disease. Approximately 30% of those glutamatergic inputs come from thalamic nuclei. Foxp2 is a transcription factor involved in cell differentiation and reported low in patients with HD. However, the role of the Foxp2 in the thalamus in HD remains unexplored., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. AG is a Ramón y Cajal fellow (RYC-2016–19466). This work was supported by grants from Ministerio de Ciencia e Innovación/ AEI/10.13039/501100011033/ and “FEDER”: AG: PID2021-122258OB-I00; MVSV: PID2020-112947RB-I00; AB: PID2019-105136RB-100; DT: PID2020-118120RB-I00; JA & MJR: PID2020-119386RB-100. Funded by H2020 Grant Agreement No. 945539 (Human Brain Project SGA3 to MVSV). IDIBAPS is funded by the CERCA program (Generalitat de Catalunya)., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Alterations of the IKZF1-IKZF2 tandem in immune cells of schizophrenia patients regulate associated phenotypes

  • Ballasch, Iván
  • López-Molina, Laura
  • Galán-Ganga, Marcos
  • Sancho-Balsells, Anna
  • Rodríguez-Navarro, Irene
  • Borràs-Pernas, Sara
  • Rabadán, M. Ángeles
  • Chen, Wanqi
  • Pastó-Pellicer, Carlota
  • Flotta, Francesca
  • Maoyu, Wang
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • Aguilar, Ruth
  • Dobaño, Carlota
  • Egri, Natalia
  • Hernández, Carla
  • Alfonso, Miqueu
  • Juan, Manel
  • Alberch, Jordi
  • Toro, Daniel del
  • Arranz, Belén
  • Canals, Josep M.
  • Giralt, Albert
Schizophrenia is a complex multifactorial disorder and increasing evidence suggests the involvement of immune dysregulations in its pathogenesis. We observed that IKZF1 and IKZF2, classic immune-related transcription factors (TFs), were both downregulated in patients' peripheral blood mononuclear cells (PBMCs) but not in their brain. We generated a new mutant mouse model with a reduction in Ikzf1 and Ikzf2 to study the impact of those changes. Such mice developed deficits in the three dimensions (positive-negative-cognitive) of schizophrenia-like phenotypes associated with alterations in structural synaptic plasticity. We then studied the secretomes of cultured PBMCs obtained from patients and identified potentially secreted molecules, which depended on IKZF1 and IKZF2 mRNA levels, and that in turn have an impact on neural synchrony, structural synaptic plasticity and schizophrenia-like symptoms in in vivo and in vitro models. Our results point out that IKZF1-IKZF2-dependent immune signals negatively impact on essential neural circuits involved in schizophrenia., This work was supported by grants from Ministerio de Ciencia e Innovación/AEI/https://doi.org/10.13039/501100011033/ and “FEDER” to A.G.: PID2021-122258OB-I00 and to J.A.: PID2020-119386RB-100 and from Instituto de Salud Carlos III (ISCIII): PI17/00246 to B.A. Our technician Ana López, was supported by a María de Maeztu Unit of Excellence (Institute of Neurosciences, University of Barcelona, CEX2021-001159-M, Ministry of Science and Innovation). The project that gave rise to these results received the support of a fellowship from “la Caixa” Foundation (ID 100010434). The fellowship code is LCF/BQ/DR21/11880016 to M.G.-G.